EIPM Member Finds More Effective Lymphoma Treatment
Rituximab Plus Lenalidomide More Effective Against Indolent Lymphoma Than Rituximab Alone The addition of an oral immunomodulatory drug to a commonly employed antibody therapy is more effective against chronic, indolent lymphoma than the antibody ...
Read more